JFJuncheng Feng

Juncheng Feng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Juncheng Feng has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • JoVE Video Dataset

    by Zhuoyang Fan, Linnan Zhang, Xiaohua Gu, Xudong Qu, Juncheng Feng, Ming Li

    Intraoperative localization of ground-glass nodules (GGNs) is challenging. This study evaluates a CT-guided protocol that innovatively combines a glucose solution test with tissue adhesive marking to enhance safety and efficacy. The standardized procedure involves preoperative thin-slice CT (≤1 mm) with a 5 × 5 cm grid for planning, followed by percutaneous puncture to a shallow (5 mm) subpleural depth. A key safety innovation is the injection of 0.3 mL of 5% glucose solution to confirm extra-bronchial needle position via cough reflex testing before depositing 0.3 mL of 2-octyl cyanoacrylate to create a palpable marker. This protocol not only achieves precise localization of pulmonary nodules but also significantly reduces the incidence of pneumothorax by minimizing the number of required puncture attempts. The method is readily reproducible and integrates seamlessly into standard preoperative workflows. This approach establishes a safer, non-radioactive alternative for GGN localization, with its core innovations -- the glucose confirmation step and shallow subpleural injection -- serving as key mechanisms for complication prevention.

  • CT-guided Preoperative Localization of Pulmonary Nodules Using a Glucose Test and Tissue Adhesive

    by Zhuoyang Fan, Linnan Zhang, Xiaohua Gu, Xudong Qu, Juncheng Feng, Ming Li

    Intraoperative localization of ground-glass nodules (GGNs) is challenging. This study evaluates a CT-guided protocol that innovatively combines a glucose solution test with tissue adhesive marking to enhance safety and efficacy. The standardized procedure involves preoperative thin-slice CT (≤1 mm) with a 5 × 5 cm grid for planning, followed by percutaneous puncture to a shallow (5 mm) subpleural depth. A key safety innovation is the injection of 0.3 mL of 5% glucose solution to confirm extra-bronchial needle position via cough reflex testing before depositing 0.3 mL of 2-octyl cyanoacrylate to create a palpable marker. This protocol not only achieves precise localization of pulmonary nodules but also significantly reduces the incidence of pneumothorax by minimizing the number of required puncture attempts. The method is readily reproducible and integrates seamlessly into standard preoperative workflows. This approach establishes a safer, non-radioactive alternative for GGN localization, with its core innovations -- the glucose confirmation step and shallow subpleural injection -- serving as key mechanisms for complication prevention.

  • Open Access

    Ultrasonography of the rectus femoris, a tool to assess the severity of sarcopenia in lung cancer patients: An observational study

    by Cheng-Chen Xu, Chen-Chen Mm Liu, Lin-Jing Mb Wang, Meng-Cheng Mb Zhang, Jun-Cheng Mm Feng, Chen-Jun Zhai, Hong-Hua Mb Pan

    Lung cancer has a higher incidence and mortality rate than other cancers do. Sarcopenia significantly affects therapeutic outcomes and prognostic prospects in patients with lung cancer. Rapid identification and early intervention for sarcopenia are priorities. Current diagnostic guidelines have limitations, particularly for nonambulatory or critically ill patients, where ultrasonography has emerged as a practical alternative. This study aims to evaluate the utility of ultrasonography in assessing skeletal muscle health and sarcopenia severity in lung cancer patients. This study was a secondary analysis of our previous research and analyzed clinical and imaging data from 82 lung cancer surgery patients and 53 benign controls. All participants underwent grayscale ultrasonography and shear wave elastography (SWE) of the rectus femoris (RF), measuring RFthick, RFcsa, RFmgv, and CSmean. Based on muscle strength and physical function, patients were categorized into 3 groups: non-sarcopenic (Group I), sarcopenic (Group II), and severely sarcopenic (Group III). Lung cancer patients exhibited lower RFthick, RFcsa, and CSmean but higher RFmgv compared to benign controls, with significant differences in RFcsa, RFmgv, and CSmean among the groups (P < .05). Additionally, RFmgv and CSmean varied significantly among lung cancer patients with different sarcopenia severities (P < .05). Ultrasonography of the RF provides objective measures for assessing skeletal muscle health in patients with lung cancer and is vital for evaluating sarcopenia severity.